publicações selecionadas
-
artigo académico
- COX-2 inhibitor delivery system aiming intestinal inflammatory disorders. Biomaterials Advances. 2024
- Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8+ß7 integrin+ T cells and anti-SARS-CoV-2 IgA response. Nature Communications. 2023
- Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8+ß7 integrin+ T cells and anti-SARS-CoV-2 IgA response. Nature Communications. 2023
- PlexinA4 mediates cytotoxic T cell trafficking and exclusion in cancer. Cancer Immunology Research. 2021
- Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia. Frontiers in Immunology. 2021
- Minimally invasive surgical treatment of pilonidal disease: Mid-term retrospective analysis of a single center. Frontiers in Pediatrics. 2019
- Influence of HOTAIR rs920778 and rs12826786 genetic variants on prostate cancer risk and progression-free survival. Biomarkers in Medicine. 2018
- Development, characterization, antioxidant and hepatoprotective properties of poly(¿-caprolactone) nanoparticles loaded with a neuroprotective fraction of Hypericum perforatum. International Journal of Biological Macromolecules. 2018
- Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis. Cell Reports. 2017
- Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells. Cell Communication and Signaling. 2017
- Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis. Journal of Neuro-Oncology. 2017
- Neuroprotective activity of Hypericum perforatum and its major components. Frontiers in Plant Science. 2016
- Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models. Genomics Data. 2015
- A Transcriptomic Signature Mediated by HOXA9 Promotes Human Glioblastoma Initiation, Aggressiveness and Resistance to Temozolomide. Oncotarget. 2015
- A Transcriptomic Signature Mediated by HOXA9 Promotes Human Glioblastoma Initiation, Aggressiveness and Resistance to Temozolomide. Oncotarget. 2015
-
documento